Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Historical perspective on prostate brachytherapy.

M Garzotto1, W R Fair

  • 1Division of Urology and the Oregon Cancer Center, Oregon Health Science University, Portland, USA.

Journal of Endourology
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.

International journal of urology : official journal of the Japanese Urological Association·2013
Same author

Erythrocyte fatty acids and prostate cancer risk: a comparison of methods.

Prostaglandins, leukotrienes, and essential fatty acids·2010
Same author

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer.

British journal of cancer·2004
Same author

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer.

Urology·2004
Same author

Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort.

BJU international·2004
Same author

Intermittent chemotherapy in metastatic androgen-independent prostate cancer.

British journal of cancer·2003
Same journal

Is Nonpapillary Puncture a Feasible Alternative to Papillary Access in Percutaneous Nephrolithotomy? A Systematic Review and Meta-Analysis.

Journal of endourology·2026
Same journal

Procedure, Safety, and Outcomes of Patient-Controlled Sedation in Ureteroscopic Lithotripsy: A 7-Year Cohort Study.

Journal of endourology·2026
Same journal

Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol.

Journal of endourology·2026
Same journal

Bubble Trouble: The Thermal Risk of Ureteral Laser Lithotripsy in an Air Bubble.

Journal of endourology·2026
Same journal

Development of an Interpretable Machine Learning Model for Predicting Clavien-Dindo Grade ≥2 Complications after Unilateral Minimally Invasive Pyeloplasty in UPJO: A Retrospective Cohort Study.

Journal of endourology·2026
Same journal

Comparison of Appendiceal Onlay Ureteroplasty and Appendiceal Interposition Ureteroplasty for Complex Proximal Ureteral Strictures in Children: Insights Gained from Long-Term Follow-Up.

Journal of endourology·2026
See all related articles

Brachytherapy, a radiation oncology technique, is now a viable prostate cancer treatment. Technological advancements have improved its efficacy and reduced complications, making it suitable for more patients.

Area of Science:

  • Radiation oncology
  • Medical physics
  • Urologic oncology

Background:

  • Brachytherapy, delivering radiation near or in tumors, originated in the early 20th century.
  • Initial adoption for prostate cancer was hindered by perceptions of radioresistance and early high failure/morbidity rates.

Observation:

  • Technological innovations, including ultrasonography and computer-assisted planning, have significantly advanced brachytherapy.
  • These advancements address previous limitations in treatment delivery and outcome prediction.

Findings:

  • Modern prostate brachytherapy, enhanced by new technologies, is now considered a reasonable treatment option.
  • Improved precision and planning contribute to better patient outcomes and reduced treatment-related morbidity.

Related Experiment Videos

Implications:

  • Prostate brachytherapy represents a significant evolution in cancer treatment, offering a less invasive option.
  • Continued technological development may further enhance the role of brachytherapy in managing prostate cancer.